Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis:

Aims:Currently, there are many approaches available for neoadjuvant therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer that improve therapeutic efficacy but are also...